Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular Ketamine vs Escitalopram and Aripiprazole in Treatment-Resistant Depression
NCT04234776Phase 4Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04234776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04234776.